[Press release] Unitaid approves new investments to accelerate equitable access to lenacapavir for HIV prevention

Unitaid press release

In December 2025, Unitaid approved an additional US$31 million to support two new projects designed with countries to expand access to lenacapavir, a twice-yearly injectable for HIV prevention. This new investment builds on Unitaid’s earlier US$22 million commitment announced in November 2024 to accelerate access to this innovative prevention option. Together, these projects complement efforts in South Africa and Zambia to roll out lenacapavir over the next three years and reinforce Unitaid’s broader work to ensure that new HIV prevention tools reach people who need them as quickly and equitably as possible.

Read the full press release here.